Live Breaking News & Updates on Imran Khan On Health
Stay updated with breaking news from Imran khan on health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pakistan-China co-produced Covid vaccine gets a great response--China Economic Net en.ce.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from en.ce.cn Daily Mail and Mail on Sunday newspapers.
This will be the second such meet on the coronavirus pandemic that has been organised by India. In March last year, India’s Prime Minister Narendra Modi had held a SAARC meet on COVID-19 pandemic. While all heads of government/state participated in the virtual meet, Islamabad had downgraded its level of participation by sending the then SAPM on health Zafar Mirza. Earlier, India had announced the establishment of an emergency fund for SAARC nations and contributed $10 million to the corpus. Posted byKoustav Das ).insertBefore(jQuery(element)); gptAdSlots[2] = googletag.defineSlot( /1007232/Indiatoday ROS MTF 1 300x250-728x90 , [[728, 90], [300, 250]], ad id s).defineSizeMapping(mapping2).setTargeting( category , [ World , WorldStory , Story , 1770159 , indiatoday-story-loop- +counter]).addService(googletag.pubads()); ....
Islamabad: Pakistan approved the emergency use of Oxford-AstraZeneca s corona vaccine. The Drug Regulatory Authority of Pakistan on Saturday authorized the Oxford University AstraZeneca Covid-19 shot. Dr. Faisal Sultan, Special Assistant to Prime Minister Imran Khan on Health, confirms making it the first vaccine to get local approval, talking to Geo News. Dr. Faisal also said adding that Pakistan has also pre-booked more than a million doses of Sinopharm s vaccine from China, awaiting approval from Drap. The vaccine company s Ad5-nCoV corona candidate is nearing completed Phase III clinical trials in Pakistan. The clinical trials of the vaccines showed the dosage to be safe and effective at preventing symptomatic covid. ....